Selection of chronic lymphocytic leukemia binding peptides

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5213-5217

  Takahashi, Satoshi ^a   Mok, Hoyin ^a,c   Parrott, M Brandon ^a   Marini III, Frank C ^d   Andreeff, Michael ^d   Brenner, Malcolm K ^a,b   Barry, Michael A ^b,c,e  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Rice University   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 MER PEPTIDE; BINDING PROTEIN; LIGAND; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHAGE DISPLAY; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; AMINO ACID SEQUENCE; GENE THERAPY; GENETIC VECTORS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LIGANDS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE LIBRARY; TRANSDUCTION, GENETIC;

EID: 0141816878     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gale, R. P., and Foon, K. A. Biology of chronic lymphocytic leukemia. Semin. Hematol., 24: 209-225, 1987.
2. Kalil, N., and Cheson, B. D. Management of chronic lymphocytic leukaemia. Drugs Aging, 16: 9-27, 2000.
3. Cantwell, M. J., Sharma, S., Friedmann, T., and Kipps, T. J. Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood, 88: 4676-4683, 1996.
4. Takahashi, S., Rousseau, R. F., Yomda, P., Mei, Z., Doui, G., Rill, D., Hurwitz, R., Marini, F., Andreeff, M., and Brenner, M. K. Autologous antileukemic immune responses induced by chronic lymphocytic leukemia cells expressing the CD40 ligand and interleukin-2 transgenes. Hum. Gene Ther., 12: 659-670, 2001.
5. Barry, M. A., Dower, W. J., and Johnston, S. A. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med., 2: 299-305, 1996.
6. Pasqualini, R., and Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature (Lond.), 380: 364-366, 1996.
7. Roskrow, M. A., Suzuki, N., Gan, Y., Sixbey, J. W., Ng, C. Y., Kimbrough, S., Hudson, M., Brenner, M. K., Heslop, H. E., and Rooney, C. M. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood, 91: 2925-2934, 1998.
8. O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., and Francis, G. E. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther., 10: 1349-1358, 1999.
9. Barry, M. A., S. Takahashi, and M. B. Parrott. Selection of peptides on phage. In: J. a. C. Douglas (ed.). Vector Targeting Strategies for Gene Therapy, p. 549-579. Hoboken, NJ: Wiley-Liss, Inc., 2002.
10. Cwirla, S. E., Balasubramanian, P., Duffin, D. J., Wagstrom, C. R., Gates, C. M., Singer, S. C., Davis, A. M., Tansik, R. L., Mattheakis, L. C., Boytos, C. M., Schatz, P. J., Baccanari, D. P., Wrighton, N. C., Barrett, R. W., and Dower, W. J. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science (Wash. DC), 276: 1696-1699, 1997.
11. Cwirla, S. E., Peters, E. A., Barrett, R. W., and Dower, W. J. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA, 87: 6378-6382, 1990.
12. Devlin, J. J., Panganiban, L. C., and Devlin, P. E. Random peptide libraries: a source of specific protein binding molecules. Science (Wash. DC), 249: 404-406, 1990.
13. Scott, J. K., and Smith, G. P. Searching for peptide ligands with an epitope library. Science (Wash. DC), 249: 386-390, 1990.
14. Koivunen, E., Gay, D. A., and Ruoslahti, E. Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J. Biol. Chem., 268: 20205-20210, 1993.
15. Gui, J., Moyana, T., Malcolm, B., and Xiang, J. Identification of a decapeptide with the binding reactivity for tumor-associated TAG72 antigen from a phage displayed library. Proteins, 24: 352-358, 1996.
16. Pasqualini, R., Koivunen, E., and Ruoslahti, E. Alpha v integrins as receptors for tumor targeting by circulating ligands [see comments]. Nat. Biotechnol., 15: 542-546, 1997.
17. Romanov, V. I., Durand, D. B., and Petrenko, V. A. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate, 47: 239-251, 2001.
18. Shadidi, M., and Sioud, M. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J., 17: 256-258, 2003.
19. Campa, M. J., Serlin, S. B., and Patz, E. F., Jr. Development of novel tumor imaging agents with phage-display combinatorial peptide libraries. Acad. Radiol., 9: 927-932, 2002.
20. Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K., and Dower, W. J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science (Wash. DC), 273: 458-464, 1996.